1 Study Coverage
1.1 Generic Injectables Product Introduction
1.2 Market Segments
1.3 Key Generic Injectables Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Generic Injectables Market Size Growth Rate by Type
1.4.2 Large Molecule Injectables (Biosimilars)
1.4.3 Small Molecule Injectables
1.5 Market by Application
1.5.1 Global Generic Injectables Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Infectious Diseases
1.5.4 Cardiology
1.5.5 Diabetes
1.5.6 Immunology
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Generic Injectables Market Size, Estimates and Forecasts
2.1.1 Global Generic Injectables Revenue 2015-2026
2.1.2 Global Generic Injectables Sales 2015-2026
2.2 Global Generic Injectables, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Generic Injectables Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Generic Injectables Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Generic Injectables Competitor Landscape by Players
3.1 Generic Injectables Sales by Manufacturers
3.1.1 Generic Injectables Sales by Manufacturers (2015-2020)
3.1.2 Generic Injectables Sales Market Share by Manufacturers (2015-2020)
3.2 Generic Injectables Revenue by Manufacturers
3.2.1 Generic Injectables Revenue by Manufacturers (2015-2020)
3.2.2 Generic Injectables Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Generic Injectables Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Generic Injectables Revenue in 2019
3.2.5 Global Generic Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Generic Injectables Price by Manufacturers
3.4 Generic Injectables Manufacturing Base Distribution, Product Types
3.4.1 Generic Injectables Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Generic Injectables Product Type
3.4.3 Date of International Manufacturers Enter into Generic Injectables Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Generic Injectables Market Size by Type (2015-2020)
4.1.1 Global Generic Injectables Sales by Type (2015-2020)
4.1.2 Global Generic Injectables Revenue by Type (2015-2020)
4.1.3 Generic Injectables Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Generic Injectables Market Size Forecast by Type (2021-2026)
4.2.1 Global Generic Injectables Sales Forecast by Type (2021-2026)
4.2.2 Global Generic Injectables Revenue Forecast by Type (2021-2026)
4.2.3 Generic Injectables Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Generic Injectables Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Generic Injectables Market Size by Application (2015-2020)
5.1.1 Global Generic Injectables Sales by Application (2015-2020)
5.1.2 Global Generic Injectables Revenue by Application (2015-2020)
5.1.3 Generic Injectables Price by Application (2015-2020)
5.2 Generic Injectables Market Size Forecast by Application (2021-2026)
5.2.1 Global Generic Injectables Sales Forecast by Application (2021-2026)
5.2.2 Global Generic Injectables Revenue Forecast by Application (2021-2026)
5.2.3 Global Generic Injectables Price Forecast by Application (2021-2026)
6 North America
6.1 North America Generic Injectables by Country
6.1.1 North America Generic Injectables Sales by Country
6.1.2 North America Generic Injectables Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Generic Injectables Market Facts & Figures by Type
6.3 North America Generic Injectables Market Facts & Figures by Application
7 Europe
7.1 Europe Generic Injectables by Country
7.1.1 Europe Generic Injectables Sales by Country
7.1.2 Europe Generic Injectables Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Generic Injectables Market Facts & Figures by Type
7.3 Europe Generic Injectables Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Generic Injectables by Region
8.1.1 Asia Pacific Generic Injectables Sales by Region
8.1.2 Asia Pacific Generic Injectables Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Generic Injectables Market Facts & Figures by Type
8.3 Asia Pacific Generic Injectables Market Facts & Figures by Application
9 Latin America
9.1 Latin America Generic Injectables by Country
9.1.1 Latin America Generic Injectables Sales by Country
9.1.2 Latin America Generic Injectables Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Generic Injectables Market Facts & Figures by Type
9.3 Central & South America Generic Injectables Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Generic Injectables by Country
10.1.1 Middle East and Africa Generic Injectables Sales by Country
10.1.2 Middle East and Africa Generic Injectables Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Generic Injectables Market Facts & Figures by Type
10.3 Middle East and Africa Generic Injectables Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Generic Injectables Products Offered
11.1.5 Pfizer Related Developments
11.2 Sandoz International
11.2.1 Sandoz International Corporation Information
11.2.2 Sandoz International Description and Business Overview
11.2.3 Sandoz International Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sandoz International Generic Injectables Products Offered
11.2.5 Sandoz International Related Developments
11.3 Baxter
11.3.1 Baxter Corporation Information
11.3.2 Baxter Description and Business Overview
11.3.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Baxter Generic Injectables Products Offered
11.3.5 Baxter Related Developments
11.4 Fresenius
11.4.1 Fresenius Corporation Information
11.4.2 Fresenius Description and Business Overview
11.4.3 Fresenius Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Fresenius Generic Injectables Products Offered
11.4.5 Fresenius Related Developments
11.5 Mylan
11.5.1 Mylan Corporation Information
11.5.2 Mylan Description and Business Overview
11.5.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Mylan Generic Injectables Products Offered
11.5.5 Mylan Related Developments
11.6 Teva Pharmaceutical
11.6.1 Teva Pharmaceutical Corporation Information
11.6.2 Teva Pharmaceutical Description and Business Overview
11.6.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Teva Pharmaceutical Generic Injectables Products Offered
11.6.5 Teva Pharmaceutical Related Developments
11.7 Hikma Pharmaceuticals
11.7.1 Hikma Pharmaceuticals Corporation Information
11.7.2 Hikma Pharmaceuticals Description and Business Overview
11.7.3 Hikma Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Hikma Pharmaceuticals Generic Injectables Products Offered
11.7.5 Hikma Pharmaceuticals Related Developments
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Corporation Information
11.8.2 Lupin Pharmaceuticals Description and Business Overview
11.8.3 Lupin Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Lupin Pharmaceuticals Generic Injectables Products Offered
11.8.5 Lupin Pharmaceuticals Related Developments
11.9 Sanofi
11.9.1 Sanofi Corporation Information
11.9.2 Sanofi Description and Business Overview
11.9.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Sanofi Generic Injectables Products Offered
11.9.5 Sanofi Related Developments
11.10 Biocon
11.10.1 Biocon Corporation Information
11.10.2 Biocon Description and Business Overview
11.10.3 Biocon Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Biocon Generic Injectables Products Offered
11.10.5 Biocon Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Generic Injectables Products Offered
11.1.5 Pfizer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Generic Injectables Market Estimates and Projections by Region
12.1.1 Global Generic Injectables Sales Forecast by Regions 2021-2026
12.1.2 Global Generic Injectables Revenue Forecast by Regions 2021-2026
12.2 North America Generic Injectables Market Size Forecast (2021-2026)
12.2.1 North America: Generic Injectables Sales Forecast (2021-2026)
12.2.2 North America: Generic Injectables Revenue Forecast (2021-2026)
12.2.3 North America: Generic Injectables Market Size Forecast by Country (2021-2026)
12.3 Europe Generic Injectables Market Size Forecast (2021-2026)
12.3.1 Europe: Generic Injectables Sales Forecast (2021-2026)
12.3.2 Europe: Generic Injectables Revenue Forecast (2021-2026)
12.3.3 Europe: Generic Injectables Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Generic Injectables Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Generic Injectables Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Generic Injectables Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Generic Injectables Market Size Forecast by Region (2021-2026)
12.5 Latin America Generic Injectables Market Size Forecast (2021-2026)
12.5.1 Latin America: Generic Injectables Sales Forecast (2021-2026)
12.5.2 Latin America: Generic Injectables Revenue Forecast (2021-2026)
12.5.3 Latin America: Generic Injectables Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Generic Injectables Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Generic Injectables Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Generic Injectables Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Generic Injectables Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Generic Injectables Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Generic Injectables Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
Pfizer、Sandoz International、Baxter、Fresenius、Mylan、Teva Pharmaceutical、Hikma Pharmaceuticals、Lupin Pharmaceuticals、Sanofi、Biocon
【免責事項】
https://www.globalresearch.jp/disclaimer